drugset / Trial / NCT00009971

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

NCT00009971

Phase 2 Completed 32 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of fenretinide in treating patients who have recurrent small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2000-11
Primary completion
2005-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fenretinide Small molecule Oral

Indications